ARCHIVES

Opdivo Study Shows 41 Percent One-Year Survival In Patients With at Least Two Past Therapies

This article is from The Cancer Letter archive.

Vol. 37 No. 11 | November 28, 2014

Download PDF Visit The Full Archive

Related Articles

AACR Academy Names 2014 Class of Fellows

April 4, 2014

FCRC Recompetition To Be Split Into Two Major Contract, For Research And “Everything Else”

September 5, 1980

Group Chairmen Propose Adding Four Trials For High Priority Status

July 6, 1990

FDA Pettiness Holds Up Trials with Promising Anticancer Drugs

November 14, 1975

Also in this 8-page issue: Amendment strips funding from two NIHM grants. NCI will commit $7 million to begin restructuring its clinical trials system, Institute director says.

July 1, 2005

Science Policy: Stem Cell Research Guidelines Formalize NIH Funding Polices

December 3, 1999